Search research articles
Contact Us
Filters
Showing results (1091-1100 of 1,129) with videos related to
Page
of 113
Sort By:
Annals of Internal Medicine
|
April 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)
Sharon A Riddler, Zoe Moodie, Jesse Clark, et al.
JMIR Pediatrics and Parenting
|
April 3, 2025
Perspectives of Adolescents and Young Adults With Inflammatory Bowel Disease on a Biopsychosocial Transition Intervention: Qualitative Interview Study
Brooke Allemang, Ashleigh Miatello, Mira Browne, et al.
Vaccine
|
July 7, 2021
AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period
Yunda Huang, Kelly E Seaton, Martin Casapia, et al.
JCI Insight
|
February 8, 2024
Predictors of HIV rebound differ by timing of antiretroviral therapy initiation
Jonathan Z Li, Meghan Melberg, Autumn Kittilson, et al.
The Journal of Infectious Diseases
|
July 11, 2013
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery
Spyros A Kalams, Scott D Parker, Marnie Elizaga, et al.
JAMA Network Open
|
June 29, 2021
Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention
Udo Hoffmann, Michael T Lu, Borek Foldyna, et al.
Ebiomedicine
|
September 30, 2022
Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens
Yunda Huang, Yuanyuan Zhang, Kelly E Seaton, et al.
The Journal of Infectious Diseases
|
February 16, 2017
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial
Holly E Janes, Kristen W Cohen, Nicole Frahm, et al.
Plos One
|
January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine
Sandhya Vasan, Sarah J Schlesinger, Zhiwei Chen, et al.
Plos One
|
August 23, 2011
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)
Gavin J Churchyard, Cecilia Morgan, Elizabeth Adams, et al.
Page
of 113
Search research articles
Search
Showing results (1091-1100 of 1,129) with videos related to
Sort By:
Page
of 113
Annals of Internal Medicine
|
April 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)
Sharon A Riddler, Zoe Moodie, Jesse Clark, et al.
JMIR Pediatrics and Parenting
|
April 3, 2025
Perspectives of Adolescents and Young Adults With Inflammatory Bowel Disease on a Biopsychosocial Transition Intervention: Qualitative Interview Study
Brooke Allemang, Ashleigh Miatello, Mira Browne, et al.
Vaccine
|
July 7, 2021
AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period
Yunda Huang, Kelly E Seaton, Martin Casapia, et al.
JCI Insight
|
February 8, 2024
Predictors of HIV rebound differ by timing of antiretroviral therapy initiation
Jonathan Z Li, Meghan Melberg, Autumn Kittilson, et al.
The Journal of Infectious Diseases
|
July 11, 2013
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery
Spyros A Kalams, Scott D Parker, Marnie Elizaga, et al.
JAMA Network Open
|
June 29, 2021
Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention
Udo Hoffmann, Michael T Lu, Borek Foldyna, et al.
Ebiomedicine
|
September 30, 2022
Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens
Yunda Huang, Yuanyuan Zhang, Kelly E Seaton, et al.
The Journal of Infectious Diseases
|
February 16, 2017
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial
Holly E Janes, Kristen W Cohen, Nicole Frahm, et al.
Plos One
|
January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine
Sandhya Vasan, Sarah J Schlesinger, Zhiwei Chen, et al.
Plos One
|
August 23, 2011
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)
Gavin J Churchyard, Cecilia Morgan, Elizabeth Adams, et al.
Page
of 113